Dr. Julia Mohr supports the Molecular Diagnostics facility of CeGaT since October 2011. She gained her scientific qualification during her academic studies in Molecular Biotechnology at the University of Bielefeld as well as during her dissertation at the University of Ulm. In her dissertation she investigated the correlation of mutations in the p53 pathway and the expression of microRNAs with the response of leukemia patients to chemotherapy.

julia.mohr {at} cegat.de